Patent holdings for IPC class A61K 31/4709

Total number of patents in this class: 5774

10-year publication summary

401
368
447
437
429
438
382
364
448
287
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
780
90
Centre National de La Recherche Scientifique
11077
62
The Regents of the University of California
20842
58
Janssen Pharmaceutica N.V.
3160
55
Bristol-myers Squibb Company
4764
53
Boehringer Ingelheim International GmbH
4485
48
Gilead Sciences, Inc.
2242
47
Arog Pharmaceuticals, Inc.
53
46
F. Hoffmann-La Roche AG
7800
43
Vertex Pharmaceuticals Incorporated
1575
43
Kura Oncology, Inc.
134
38
Universite de Montpellier
1043
37
Novartis AG
10175
36
Institut Curie
621
36
Merck Sharp & Dohme LLC
3738
35
Abivax
135
34
Forma Therapeutics, Inc.
148
34
Merck Patent GmbH
5739
33
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
876
33
Amgen Inc.
4436
32
Other owners 4881